Cambridge Investment Research Advisors, Inc. Iovance Biotherapeutics, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.6 Billion
- Q1 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 45,877 shares of IOVA stock, worth $135,337. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45,877
Previous 40,640
12.89%
Holding current value
$135,337
Previous $301,000
49.17%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding IOVA
# of Institutions
322Shares Held
247MCall Options Held
1.34MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA27.8MShares$81.9 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$72 Million12.15% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$62.6 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY12.7MShares$37.5 Million1.77% of portfolio
-
State Street Corp Boston, MA11MShares$32.6 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $466M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...